Kaya Technologies is a sister concern of KayaMed, a Canadian corporation that has been working for the last two years to build a system to produce and supply the highest quality of pharmaceutical-grade marihuana in accordance with the Controlled Drugs and Substances Act, the Marihuana for Medical Purposes Regulations (MMPR).
We have now reached a proven system, built on state of the art production facilities and a cultivation system that maximizes product quality and yield. KayaMed will become a leader in the industry by providing a variety of premium quality, low cost medical marihuana that will address the specific needs of Medical Marijuana consumers.
We are now in the process of advancing an application for license to grow and distribute medical marijuana under Health Canada’s Marihuana for Medical Purposes Regulations (MMPR) program.
We now invite investors who can contribute to the growth of medical marijuana industry. Our aim to build and expand state-of-the-art cannabis cultivation sites for maximum quality yield and work place efficiency.
Responsible funding in this domain will advance the science of cannabis, improve the quality of life for patients and also clear the fallacies that are otherwise associated with the plant.
What’s in it for you?
With their advisory services and managed operations, our industry experts will help you to maximize your investment returns and mitigate risks. KayaMed’s industry proficiency can help you convert event-driven opportunities into strong drivers of portfolio returns.
Together with Kaya Technologies, KayaMed will work to protect investors’ capital by consistently implementing stringent compliance standards to all its operations.
To step forward for the medical marijuana revolution, contact our team on 1-800-862-9390